183 related articles for article (PubMed ID: 9335448)
1. Foscan-mediated photodynamic therapy for a peritoneal-cancer model: drug distribution and efficacy studies.
Veenhuizen RB; Ruevekamp MC; Oppelaar H; Helmerhorst TJ; Kenemans P; Stewart FA
Int J Cancer; 1997 Oct; 73(2):230-5. PubMed ID: 9335448
[TBL] [Abstract][Full Text] [Related]
2. Does tumour uptake of Foscan determine PDT efficacy?
Veenhuizen R; Oppelaar H; Ruevekamp M; Schellens J; Dalesio O; Stewart F
Int J Cancer; 1997 Oct; 73(2):236-9. PubMed ID: 9335449
[TBL] [Abstract][Full Text] [Related]
3. Foscan uptake and tissue distribution in relation to photodynamic efficacy.
Cramers P; Ruevekamp M; Oppelaar H; Dalesio O; Baas P; Stewart FA
Br J Cancer; 2003 Jan; 88(2):283-90. PubMed ID: 12610515
[TBL] [Abstract][Full Text] [Related]
4. Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model.
Rovers JP; Saarnak AE; Molina A; Schuitmaker JJ; Sterenborg HJ; Terpstra OT
Br J Cancer; 1999 Oct; 81(4):600-8. PubMed ID: 10574244
[TBL] [Abstract][Full Text] [Related]
5. Foscan-based photodynamic treatment in vivo: correlation between efficacy and Foscan accumulation in tumor, plasma and leukocytes.
Maugain E; Sasnouski S; Zorin V; Merlin JL; Guillemin F; Bezdetnaya L
Oncol Rep; 2004 Sep; 12(3):639-45. PubMed ID: 15289849
[TBL] [Abstract][Full Text] [Related]
6. Localization of liposomal mTHPC formulations within normal epithelium, dysplastic tissue, and carcinoma of oral epithelium in the 4NQO-carcinogenesis rat model.
de Visscher SA; Witjes MJ; van der Vegt B; de Bruijn HS; van der Ploeg-van den Heuvel A; Amelink A; Sterenborg HJ; Roodenburg JL; Robinson DJ
Lasers Surg Med; 2013 Dec; 45(10):668-78. PubMed ID: 24174342
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of tetra(m-hydroxyphenyl)chlorin in the hamster cheek pouch tumor model: comparison with clinical measurements.
Glanzmann T; Forrer M; Blant SA; Woodtli A; Grosjean P; Braichotte D; van den Bergh H; Monnier P; Wagnières G
J Photochem Photobiol B; 2000 Aug; 57(1):22-32. PubMed ID: 11100834
[TBL] [Abstract][Full Text] [Related]
8. Intraperitoneal photodynamic therapy of the rat CC531 adenocarcinoma.
Veenhuizen RB; Marijnissen JP; Kenemans P; Ruevekamp-Helmers MC; 't Mannetje LW; Helmerhorst TJ; Stewart FA
Br J Cancer; 1996 Jun; 73(11):1387-92. PubMed ID: 8645584
[TBL] [Abstract][Full Text] [Related]
9. Optimal treatment opportunity for mTHPC-mediated photodynamic therapy of liver cancer.
Wang JD; Shen J; Zhou XP; Shi WB; Yan JH; Luo FH; Quan ZW
Lasers Med Sci; 2013 Nov; 28(6):1541-8. PubMed ID: 23377406
[TBL] [Abstract][Full Text] [Related]
10. Foscan and foslip based photodynamic therapy in osteosarcoma in vitro and in intratibial mouse models.
Meier D; Botter SM; Campanile C; Robl B; Gräfe S; Pellegrini G; Born W; Fuchs B
Int J Cancer; 2017 Apr; 140(7):1680-1692. PubMed ID: 27943293
[TBL] [Abstract][Full Text] [Related]
11. Compartmental targeting for mTHPC-based photodynamic treatment in vivo: Correlation of efficiency, pharmacokinetics, and regional distribution of apoptosis.
Garrier J; Bressenot A; Gräfe S; Marchal S; Mitra S; Foster TH; Guillemin F; Bezdetnaya L
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):563-71. PubMed ID: 20656417
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of meta-tetrahydroxyphenylchlorin-sensitized photodynamic treatment on human tumor xenografts using a water-soluble vitamin E analogue, Trolox.
Melnikova VO; Bezdetnaya LN; Brault D; Potapenko AY; Guillemin F
Int J Cancer; 2000 Dec; 88(5):798-803. PubMed ID: 11072251
[TBL] [Abstract][Full Text] [Related]
13. Optimisation of illumination for photodynamic therapy with mTHPC on normal colon and a transplantable tumour in rats.
Tsutsui H; MacRobert AJ; Curnow A; Rogowska A; Buonaccorsi G; Kato H; Bown SG
Lasers Med Sci; 2002; 17(2):101-9. PubMed ID: 12111593
[TBL] [Abstract][Full Text] [Related]
14. Uptake and localisation of mTHPC (Foscan) and its 14C-labelled form in normal and tumour tissues of the hamster squamous cell carcinoma model: a comparative study.
Blant SA; Glanzmann TM; Ballini JP; Wagnières G; van den Bergh H; Monnier P
Br J Cancer; 2002 Dec; 87(12):1470-8. PubMed ID: 12454779
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy for malignant mesothelioma: preclinical studies for optimization of treatment protocols.
Schouwink H; Ruevekamp M; Oppelaar H; van Veen R; Baas P; Stewart FA
Photochem Photobiol; 2001 Apr; 73(4):410-7. PubMed ID: 11332037
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy of a transplanted pancreatic cancer model using meta-tetrahydroxyphenylchlorin (mTHPC).
Mikvy P; Messman H; MacRobert AJ; Pauer M; Sams VR; Davies CL; Stewart JC; Bown SG
Br J Cancer; 1997; 76(6):713-8. PubMed ID: 9310235
[TBL] [Abstract][Full Text] [Related]
17. Correlation between in vivo pharmacokinetics, intratumoral distribution and photodynamic efficiency of liposomal mTHPC.
Lassalle HP; Dumas D; Gräfe S; D'Hallewin MA; Guillemin F; Bezdetnaya L
J Control Release; 2009 Mar; 134(2):118-24. PubMed ID: 19100297
[TBL] [Abstract][Full Text] [Related]
18. Improved in vivo delivery of m-THPC via pegylated liposomes for use in photodynamic therapy.
Bovis MJ; Woodhams JH; Loizidou M; Scheglmann D; Bown SG; Macrobert AJ
J Control Release; 2012 Jan; 157(2):196-205. PubMed ID: 21982898
[TBL] [Abstract][Full Text] [Related]
19. Intraperitoneal photodynamic therapy: comparison of red and green light distribution and toxicity.
Veenhuizen RB; Ruevekamp MC; Oppelaar H; Ransdorp B; van de Vijver M; Helmerhorst TJ; Kenemans P; Stewart FA
Photochem Photobiol; 1997 Sep; 66(3):389-95. PubMed ID: 9297983
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy with mTHPC and polyethylene glycol-derived mTHPC: a comparative study on human tumour xenografts.
Ris HB; Krueger T; Giger A; Lim CK; Stewart JC; Althaus U; Altermatt HJ
Br J Cancer; 1999 Mar; 79(7-8):1061-6. PubMed ID: 10098737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
